Merck Frosst
Patients and Caregivers

Children and adolescents (12 months to 17 years of age)

  • 1st dose: may be given at any time

  • 2nd dose (booster): 6 to 18 months after the first dose

Adults 18 years of age and older

  • 1st dose: may be given at any time

  • 2nd dose (booster): 6 months after the first dose

Drug Identification Number (DIN): 02229702

VAQTA® may be covered by your private health insurance plan. Please check your individual coverage.

This product information is intended only for residents of Canada.

®Registered Trademark of Merck & Co., Inc. Used under license.

This site is for residents of Canada. / This site was updated on October 26, 2011.